Hochuan Medical Brings in ￥10 Million in a Series A round

(VCBeat) July. 12, 2021 -- Recently, Shenzhen Hochuan Medical Technology Co., Ltd. ("Hochuan Medical") has raised tens of millions of yuan in a Series A financing, led by Qiming Venture Partners as the sole investor. Proceeds from this round will be used to accelerate the expansion of Hochuan Medical's CDMO business in both international and domestic markets, as well as the development of new technologies and manufacturing processes and capacity improvement.

Hochuen Medical is one of the largest OEM/ODM manufacturers for In Vitro Diagnostics (IVD), medical disposables & devices, and wearable medical products. We provide "one-stop" services for IVD customers and can provide support from the R&D and prototyping phases to low and high volume CDMO manufacturing on micofluidic chips and biomedical consumables.

Hochuen Medical is FDA registered and ISO 13485 certified. Our manufacturing sites consist of class 10k-100k cleanrooms and a GMP facility. Hochuen Medical is headquartered in Shenzhen, China, and has offices in Los Angeles, USA and Singapore. They are also establishing a new manufacturing site in Malaysia.

The microfluidic technology started late in China, and many advanced technologies are relatively immature. Hochuan Medical has been committed to the continuous exploration and R&D of microfluidic technology since its establishment. Now the company has foreign top brands of ultra-precision injection molding machines and high-precision CNC mold machines, with self-developed ultra-precision laser cutting and high-precision die-cutting and chip bonding process, as well as wet and dry reagents and chip assembly, enabling the industrialization of microfluidic technology.

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Shenzhen, Hong Kong, Seattle, Boston, and San Francisco Bay Area. Currently, Qiming Venture Partners manages seven US Dollar funds and five RMB funds with over US$4 billion assets under management. Qiming Venture Partners invests in information technology, new consumer business patterns, and the healthcare sector.